Sentences with phrase «producing gene and cell therapies»

It's about co-funding industrial facilities for developing and producing gene and cell therapies, and to build up a new economic sector.

Not exact matches

ORDINARY cells from people with a genetic disease can be «fixed» by gene therapy and then reprogrammed to be stem cells that will produce a limitless supply of defect - free cells.
In the recessive deafness model, gene therapy with TMC1 restored the ability of sensory hair cells to respond to sound — producing a measurable electrical current — and also restored activity in the auditory portion of the brainstem.
For the animal experiments, Savio Woo of the Center for Gene Therapy at Baylor College of Medicine in Houston and his colleagues first isolated liver cells from transgenic mice that produce the human protein a1 - antitrypsin in their livers, from where it is secreted into the blood.
Many life - saving products, such as recombinant therapeutic proteins, vaccines, and gene therapy vectors, are produced from large - scale cell culture systems.
In the health care industry, many life - saving products, such as recombinant therapeutic proteins, vaccines, and gene therapy vectors, are produced from large - scale cell culture systems.
The technology also improves cell culture systems used to produce therapeutic proteins, vaccines, and gene therapy vectors.
Some researchers seek gene therapies that might act more broadly on retinal cells, perhaps by using genes that produce proteins supporting the growth and health of nerve cells, which could be delivered before significant vision loss occurs.
The first step in both direct and cell - based gene therapy is packaging a therapeutic transgene into a delivery vehicle (e.g., a viral vector), followed by expansion of its host cell lines to produce high - enough vector concentrations.
In addition to its emphasis on producing vaccines, the lab specializes in gene and cell therapies, including stem cell products.
«The Department of Health and its Gene Therapy Advisory Committee are currently working with other regulators in the field to produce a «Regulatory Route Map» to provide further clarity on the regulatory requirements for the clinical use of stem cells
a b c d e f g h i j k l m n o p q r s t u v w x y z